HHLR ADVISORS, LTD.
โขCIK: 1762304โขFiling: Q4 2025
HHLR Advisors, Ltd., managed by the seasoned team of Harry Halperin and Robert R. Looney, is known for its concentrated, high-conviction bets, currently holding 33 positions with a focus on Chinese tech and biotech sectors. Recently, the fund has increased its stakes in Maze and PacBio, while significantly reducing exposure to NRSCF and YSG, reflecting a strategic pivot towards growth in biotechnology and digital health.
Total AUM
$3.1B
QoQ Performance
-24.1%
Positions
32
Top 10 Concentration
96.1%
Latest Filing
Q4 2025
Top Holdings Allocation
PDD
BABA
ONC
FUTU
PDD39.2%
BABA25.6%
ONC10.1%
FUTU8.6%
LEGN4.2%
AVBP2.5%
BEKE2.2%
WEBULL1.5%
๐ Biggest Buys
๐ Biggest Sells
Sector Breakdown
Other99.8%
Industrial0.1%
Technology0.1%
๐ช Exited Positionssold since Q3 2025
+1 more exited positions
Changes from Q3 2025
NEW6 new positions
โ2 increased
โ3 decreased
Historical Filings
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023